Jon Stonehouse

(Mr. Jon Stonehouse)

Currently holds positions in Bellicum Pharmaceuticals Inc and BioCryst Pharmaceuticals Inc

Positions

Position Company Period
Independent Director Bellicum Pharmaceuticals Inc Dec. 5, 2014 -
President, Chief Executive Officer, Director BioCryst Pharmaceuticals Inc July 13, 2007 -
Jon Stonehouse's trades of BioCryst Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-15 2024-05-13
B Purchase
30,000 +2.7%
5.55
USD 166,500 		30,000 +2.7% 5.55 USD 166,500
2023-02-02 2023-02-01
PS Planned sale
100,000 -9.0%
10.38
USD 1,038,000 		100,000 -9.0% 10.38 USD 1,038,000
2022-12-19 2022-12-15
PS Planned sale
14,100 -1.6%
10.90
USD 153,690 		14,100 -1.6% 10.90 USD 153,690
2022-12-02 2022-12-02
PS Planned sale
82,656 -8.4%
12.80
USD 1,057,997 		82,656 -8.4% 12.80 USD 1,057,997
2022-12-02 2022-12-01
PS Planned sale
214,917 -19.2%
13.00
USD 2,793,921 		214,917 -19.2% 13.00 USD 2,793,921
2022-01-13 2022-01-11
PS Planned sale
184,000 -16.9%
15.04
USD 2,767,360 		184,000 -16.9% 15.04 USD 2,767,360
2020-12-17 2020-12-15
PS Planned sale
134,278 -14.6%
8.32
USD 1,117,193 		134,278 -14.6% 8.32 USD 1,117,193
// ... existing code ... // ... rest of the file ...